86 related articles for article (PubMed ID: 19494402)
1. Predictors of target lesion revascularization in patients undergoing lower extremity percutaneous interventions.
Shammas NW; Shammas G; Bryan D; Rauba J; Dippel E; Jerin M
J Invasive Cardiol; 2009 Jun; 21(6):266-9. PubMed ID: 19494402
[TBL] [Abstract][Full Text] [Related]
2. Statin therapy may prevent restenosis after successful coronary intervention, independent of lipid-lowering effect and CRP level.
Yamawaki T; Yamada A; Fukumoto Y; Kishi T; Sobashima A; Kuwata K; Nakamura R; Sekiya M; Ando H; Okamatsu S
Fukuoka Igaku Zasshi; 2007 Jun; 98(6):260-9. PubMed ID: 17665547
[TBL] [Abstract][Full Text] [Related]
3. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of homocysteine levels in patients receiving coronary stenting for unstable angina.
Ortolani P; Marzocchi A; Marrozzini C; Palmerini T; Aquilina M; Corlianò L; Saia F; Taglieri N; Sbarzaglia P; Bacchi Reggiani ML; Branzi A
Ital Heart J; 2004 Mar; 5(3):189-96. PubMed ID: 15119501
[TBL] [Abstract][Full Text] [Related]
5. Combined periprocedural evaluation of CRP and TNF-alpha enhances the prediction of clinical restenosis and major adverse cardiac events in patients undergoing percutaneous coronary interventions.
Kubica J; Kozinski M; Krzewina-Kowalska A; Zbikowska-Gotz M; Dymek G; Sukiennik A; Piasecki R; Bogdan M; Grzesk G; Chojnicki M; Dziedziczko A; Sypniewska G
Int J Mol Med; 2005 Jul; 16(1):173-80. PubMed ID: 15942695
[TBL] [Abstract][Full Text] [Related]
6. Periprocedural soluble P- and E-selectin levels fail as predictors of clinical restenosis in patients treated with elective coronary stenting.
Kozinski M; Kubica J; Sukiennik A; Zbikowska-Gotz M; Krzewina-Kowalska A; Radomski M; Rychter M; Bialoszynski T; Jablonski M; Demidowicz K; Grzesk G; Bogdan M; Chojnicki M; Grabczewska S; Dziedziczko A
Int J Mol Med; 2007 Jan; 19(1):187-95. PubMed ID: 17143564
[TBL] [Abstract][Full Text] [Related]
7. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
Morange PE; Bickel C; Nicaud V; Schnabel R; Rupprecht HJ; Peetz D; Lackner KJ; Cambien F; Blankenberg S; Tiret L;
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2793-9. PubMed ID: 17023678
[TBL] [Abstract][Full Text] [Related]
8. Effect of gradual computerized angioplasty on outcomes of patients undergoing coronary stenting.
Leibowitz D; Lotan C; Katz I; Nassar H; Boguslavsky L; Mosseri M; Jabara R; Varshitzsky B; Danenberg H; Weiss AT
Am J Cardiol; 2009 Jul; 104(2):223-6. PubMed ID: 19576351
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus-eluting stent treatment at high-volume centers confers lower mortality at 6-month follow-up: results from the prospective multicenter German Cypher Registry.
Khattab AA; Hamm CW; Senges J; Toelg R; Geist V; Bonzel T; Kelm M; Levenson B; Nienaber CA; Pfannebecker T; Sabin G; Schneider S; Tebbe U; Neumann FJ; Richardt G;
Circulation; 2009 Aug; 120(7):600-6. PubMed ID: 19652087
[TBL] [Abstract][Full Text] [Related]
10. Plasma leptin and prognosis in patients with established coronary atherosclerosis.
Wolk R; Berger P; Lennon RJ; Brilakis ES; Johnson BD; Somers VK
J Am Coll Cardiol; 2004 Nov; 44(9):1819-24. PubMed ID: 15519013
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-3 is elevated in patients with coronary artery disease and predicts restenosis after percutaneous coronary intervention.
Rudolph T; Schaps KP; Steven D; Koester R; Rudolph V; Berger J; Terres W; Meinertz T; Kaehler J
Int J Cardiol; 2009 Mar; 132(3):392-7. PubMed ID: 18378332
[TBL] [Abstract][Full Text] [Related]
12. Blood fluidity and outcome after femoropopliteal percutaneous transluminal angioplasty (PTA): role of plasma viscosity and low platelet count in predicting restenosis.
van der Loo B; Kovacevic T; Krieger E; Banyai S; Banyai M; Amann-Vesti BR; Jagacic D; Rousson V; Koppensteiner R
Clin Hemorheol Microcirc; 2005; 32(2):159-68. PubMed ID: 15764824
[TBL] [Abstract][Full Text] [Related]
13. [Coronary angioplasty on calcified lesions].
Alfonso F; Macaya C; Iñiguez A; Fernández-Ortiz A; Zarco P
Rev Esp Cardiol; 1990 Apr; 43(4):231-8. PubMed ID: 2353122
[TBL] [Abstract][Full Text] [Related]
14. [Acute phase proteins and recurrence of angina after effective coronary angioplasty].
Alekseeva IA; Liakishev AA; Tkachuk VA; Dobrovol'skiĭ AB; Nasonov EL; Naumov VG; Parfenova EV
Ter Arkh; 2002; 74(4):42-5. PubMed ID: 12043237
[TBL] [Abstract][Full Text] [Related]
15. Cost determinants of percutaneous and surgical interventions for treatment of intermittent claudication from the perspective of the hospital.
Janne d'Othée B; Morris MF; Powell RJ; Bettmann MA
Cardiovasc Intervent Radiol; 2008; 31(1):56-65. PubMed ID: 17973158
[TBL] [Abstract][Full Text] [Related]
16. Obesity and clinical restenosis after coronary stent placement.
Rana JS; Mittleman MA; Ho KK; Cutlip DE
Am Heart J; 2005 Oct; 150(4):821-6. PubMed ID: 16209988
[TBL] [Abstract][Full Text] [Related]
17. Relationship between the adipose-tissue hormone resistin and coronary artery disease.
Hoefle G; Saely CH; Risch L; Koch L; Schmid F; Rein P; Aczél S; Berchtold S; Drexel H
Clin Chim Acta; 2007; 386(1-2):1-6. PubMed ID: 17706624
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of serum high-density lipoprotein cholesterol level as an independent predictor of one-year mortality after percutaneous coronary interventions.
Ghazzal ZB; Dhawan SS; Sheikh A; Douglas JS; Veledar E; Mavromatis K; Pohlel FK; Vaccarino V
Am J Cardiol; 2009 Apr; 103(7):902-6. PubMed ID: 19327413
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of D-Dimers and fibrinogen plasma determination in patients with polyvascular disease.
Bosevski M; Kostoska S; Tosev S; Borozanov V
Angiol Sosud Khir; 2006; 12(2):9-15. PubMed ID: 17053757
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein, fibrin D-dimer, and risk of ischemic heart disease: the Caerphilly and Speedwell studies.
Lowe GD; Sweetnam PM; Yarnell JW; Rumley A; Rumley C; Bainton D; Ben-Shlomo Y
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1957-62. PubMed ID: 15308549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
